Hormonal Male Contraception: Getting to Market is a research paper published in Frontiers in Endocrinology (2022). On theSindex it has a DataRank of 1.1. It has been cited 29 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0.615
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
NICHD NIH HHS
Grant: HHSN275201300024I
NICHD NIH HHS
Grant: P50 HD098593
NICHD NIH HHS
Grant: HHSN275201300025I
NCATS NIH HHS
Grant: UL1 TR001881
National Institutes of Health
Grant: 3UL1TR001881-01S2
UCLA Clinical Translational Science Institute
National Institutes of Health
Grant: 5P50HD098593-03
Center for Male Reproductive Epigenomics
FWCI
3.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals